Clinical trials

  • TULMIMETOSTAT for Metastatic hormone-sensitive prostate cancer
  • LY3537031 for Liver impairment (hepatic insufficiency) | Healthy volunteers
  • BLINATUMOMAB for Granulomatosis with polyangiitis | Systemic lupus erythematosus | Systemic sclerosis
  • NBI-1117570 for Schizophrenia
  • APREPITANT for Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors | Acneiform eruption
  • IDOR-1117-2520C for Chronic plaque psoriasis (moderate to severe)|Psoriatic arthritis
  • SPY072 for Rheumatoid arthritis|Psoriatic arthritis|Axial spondyloarthritis
  • R2R01 for Cardiac surgery-associated acute kidney injury (CSA-AKI) | Acute kidney injury
  • 4-iodophenylalanine I-131 for Glioblastoma
  • Semaglutide for Chronic kidney disease
  • REGN7041 for Non-infectious uveitis | Posterior segment uveitis
  • Ferrous sulfate for Iron deficiency